Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer

Clinical trial NCT06434064 · RECRUITING

Trial details

NCT number: NCT06434064
Sponsor: Roswell Park Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 Locally Advanced Unresectable Triple-Negative Breast Carcinoma Metastatic Triple-Negative Breast Carcinoma

Start date: 2026-03-03
Primary completion: 2028-11-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.